Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.25 CAD -3.85%
Market Cap: 89m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Gross Profit
CA$16.5m
CAGR 3-Years
4%
CAGR 5-Years
-6%
CAGR 10-Years
9%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Gross Profit
$64.9m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
41%
ESSA Pharma Inc
NASDAQ:EPIX
Gross Profit
-$99.2k
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Gross Profit
$192.3m
CAGR 3-Years
107%
CAGR 5-Years
N/A
CAGR 10-Years
71%
Spectral Medical Inc
TSX:EDT
Gross Profit
CA$798k
CAGR 3-Years
-17%
CAGR 5-Years
-25%
CAGR 10-Years
-10%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
89m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Overvaluation 16%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Gross Profit?
Gross Profit
16.5m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Gross Profit amounts to 16.5m CAD.

What is Covalon Technologies Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
9%

Over the last year, the Gross Profit growth was 29%. The average annual Gross Profit growth rates for Covalon Technologies Ltd have been 4% over the past three years , -6% over the past five years , and 9% over the past ten years .

Back to Top